On May 23, 2025, Adial Pharmaceuticals, Inc. was notified by Nasdaq that its stockholders’ equity of $2,126,662 is below the required minimum of $2,500,000, and it has until July 7, 2025, to submit a Compliance Plan to regain compliance.